Join us in the fascinating, world class National Institute for Bioprocessing Research and Training to learn how Analytics and AI is being employed by global leading companies in Health Science to revolutionise the industry.
Our speakers include:
Frank Cordes, Partner and Managing Director, Boston Consulting Group
Frank Cordes is a Partner in the London office of The Boston Consulting Group. Frank leads the firm’s Operations practice in Western Europe and South America, BCG’s Biopharma Operations team in Europe and the topic of Digital Operations in biopharmaceutical operations globally.
Today, Frank is working with biopharmaceutical manufacturers on applying Digital technology and Advanced Analytics to improve their Supply Chain and Manufacturing performance. He has overseen several Digital Supply Chain implementations, the design and implementation of digitally enabled Production Systems as well as a range of analytics and AI-driven projects focused on the release of capacity constraints, quality improvements or cost savings.
Frank has a DPhil and MSc in Molecular Biophysics from the University of Oxford. He is a German national and studied at the Freie Universität in Berlin, at the Ecole Normale Supérieure in Paris and at Oxford University.
Dr Colin Clarke, Principal Investigator, National Institute for Bioprocessing Research and Training
Dr. Clarke graduated with a PhD in Bioinformatics from Cranfield University, UK, and specialises in the application of multivariate statistics and machine learning algorithms to high dimensional data. Upon completion of his doctoral training Colin took a position at Dublin Institute of Technology (DIT) applying chemometric approaches to analyse Raman and Infrared spectroscopy data from cells and tissues.
He moved to the National Institute for Cellular Biotechnology at Dublin City University in 2009.
In 2014 he moved to NIBRT following the award of SFI’s prestigious Starting Investigator Research Grant. Dr Clarke’s bioinformatics group is currently focussed on further understanding of the CHO cell biological system using next generation sequencing and advanced computational techniques.
John Savage, Data Scientist, Nuritas F
‘From code to cures: the data pipeline at Nuritas’
John Savage is a Data Scientist at Nuritas, an artificial intelligence biotechnology company revolutionising the discovery of novel, natural and scientifically proven active ingredients that can manage and improve human health.
John received his PhD in Theoretical Chemistry from the University of Chicago where he simulated the movement of molecules in complex systems in order to design the next generation of materials for hydrogen fuel cells. After his PhD, John applied machine learning and data analytics to industry problems. At IBM Research, he developed a patent-pending machine learning system to recommend novel reactions to organic chemists. At Deutsche Bank Data Lab, he built robust, scalable text matching and entity resolution systems to identify clients linked to adverse media events.
John joined Nuritas in 2016 where he sits at the intersection of the R&D lab, computational team, and operations. He leads a team that models large volumes of proteomics data produced in-house, efficiently feeds the machine learning pipelines, and delivers insights back to the business through interactive visualisations and dashboards.